0 130

Cited 81 times in

Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein

DC FieldValueLanguage
dc.contributor.author류철형-
dc.date.accessioned2016-02-04T11:16:33Z-
dc.date.available2016-02-04T11:16:33Z-
dc.date.issued2015-
dc.identifier.issn0161-5505-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/140061-
dc.description.abstractAlzheimer disease (AD) is associated with an increase in the brain of the 18-kDa translocator protein (TSPO), which is overexpressed in activated microglia and reactive astrocytes. Measuring the density of TSPO with PET typically requires absolute quantitation with arterial blood sampling, because a reference region devoid of TSPO does not exist in the brain. We sought to determine whether a simple ratio method could substitute for absolute quantitation of binding with (11)C-PBR28, a second-generation radioligand for TSPO. METHODS: (11)C-PBR28 PET imaging was performed in 21 healthy controls, 11 individuals with mild cognitive impairment, and 25 AD patients. Group differences in (11)C-PBR28 binding were compared using 2 methods. The first was the gold standard method of calculating total distribution volume (V(T)), using the 2-tissue-compartment model with the arterial input function, corrected for plasma-free fraction of radiotracer (f(P)). The second method used a ratio of brain uptake in target regions to that in cerebellum-that is, standardized uptake value ratio (SUVR). RESULTS: Using absolute quantitation, we confirmed that TSPO binding (V(T)/f(P)) was greater in AD patients than in healthy controls in expected temporoparietal regions and was not significantly different among the 3 groups in the cerebellum. When the cerebellum was used as a pseudo-reference region, the SUVR method detected greater binding in AD patients than controls in the same regions as absolute quantification and in 1 additional region, suggesting SUVR may have greater sensitivity. Coefficients of variation of SUVR measurements were about two-thirds lower than those of absolute quantification, and the resulting statistical significance was much higher for SUVR when comparing AD and healthy controls (e.g., P < 0.0005 for SUVR vs. P = 0.023 for VT/fP in combined middle and inferior temporal cortex). CONCLUSION: To measure TSPO density in AD patients and control subjects, a simple ratio method SUVR can substitute for, and may even be more sensitive than, absolute quantitation. The SUVR method is expected to improve subject tolerability by allowing shorter scanning time and not requiring arterial catheterization. In addition, this ratio method allows smaller sample sizes for comparable statistical significance because of the relatively low variability of the ratio values.-
dc.description.statementOfResponsibilityopen-
dc.format.extent701~706-
dc.relation.isPartOfJOURNAL OF NUCLEAR MEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAged-
dc.subject.MESHAlzheimer Disease/diagnostic imaging*-
dc.subject.MESHAlzheimer Disease/metabolism*-
dc.subject.MESHCerebellum/diagnostic imaging-
dc.subject.MESHCerebellum/metabolism*-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHInflammation/diagnostic imaging-
dc.subject.MESHInflammation/metabolism-
dc.subject.MESHLigands-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHPositron-Emission Tomography*-
dc.subject.MESHProtein Binding-
dc.subject.MESHPyrimidines/metabolism*-
dc.subject.MESHReceptors, GABA/metabolism*-
dc.subject.MESHReference Standards-
dc.titleCerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Neurology (신경과학)-
dc.contributor.googleauthorChul Hyoung Lyoo-
dc.contributor.googleauthorMasamichi Ikawa-
dc.contributor.googleauthorJeih San Liow-
dc.contributor.googleauthorSami S. Zoghbi-
dc.contributor.googleauthorCheryl L. Morse-
dc.contributor.googleauthorVictor W. Pike-
dc.contributor.googleauthorMasahiro Fujita-
dc.contributor.googleauthorRobert B. Innis-
dc.contributor.googleauthorWilliam Charles Kreisl-
dc.identifier.doi10.2967/jnumed.114.146027-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01333-
dc.relation.journalcodeJ01644-
dc.identifier.eissn1535-5667-
dc.identifier.pmid25766898-
dc.identifier.urlhttp://jnm.snmjournals.org/content/56/5/701-
dc.subject.keyword11C-PBR28-
dc.subject.keywordAlzheimer disease-
dc.subject.keywordneuroinflammation-
dc.subject.keywordpositron emission tomography-
dc.subject.keywordratio method-
dc.contributor.alternativeNameLyoo, Chul Hyoung-
dc.contributor.affiliatedAuthorLyoo, Chul Hyoung-
dc.rights.accessRightsnot free-
dc.citation.volume56-
dc.citation.number5-
dc.citation.startPage701-
dc.citation.endPage706-
dc.identifier.bibliographicCitationJOURNAL OF NUCLEAR MEDICINE, Vol.56(5) : 701-706, 2015-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.